Clinical Trial Update: Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes

View source ↗

Summary

AstraZeneca's clinical trial update identifies risk factors for low lymphocyte counts in patients with type 2 diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED